NorthSea Therapeutics raises $40m to develop NASH drugDutch biotech NorthSea Therapeutics has raised around $40 million in a series B financing round to help it Share XNorthSea Therapeutics raises $40m to develop NASH drughttps://pharmaphorum.com/news/northsea-therapeutics/